Interesting V

PRESCIENT THERAPEUTICS LIMITEDASX

描述

⋅ 2016年10月25日早上8點40分

So this is another clinical stager.... Coming along with PTX100 and PTX200 studied for breast cancer and incombination with citarabine for acute myeloid leukemia. Technically all levels above 0,13 are a buy!

biotech